The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa
Open accessAbstract
BACKGROUND: We hypothesized that mass distribution of a broad-spectrum antibiotic agent to preschool children would reduce mortality in areas of sub-Saharan Africa that are currently far from meeting the Sustainable Development Goals of the United Nations. METHODS: In this cluster-randomized trial, we assigned communities in Malawi, Niger, and Tanzania to four twice-yearly mass distributions of either oral azithromycin (approximately 20 mg per kilogram of body weight) or placebo. Children 1 to 59 months of age were identified in twice-yearly censuses and were offered participation in the trial. Vital status was determined at subsequent censuses. The primary outcome was aggregate all-cause mortality; country-specific rates were assessed in prespecified subgroup analyses. RESULTS: A total of 1533 communities underwent randomization, 190,238 children were identified in the census at baseline, and 323,302 person-years were monitored. The mean (±SD) azithromycin and placebo coverage over the four twice-yearly distributions was 90.4±10.4%. The overall annual mortality rate was 14.6 deaths per 1000 person-years in communities that received azithromycin (9.1 in Malawi, 22.5 in Niger, and 5.4 in Tanzania) and 16.5 deaths per 1000 person-years in communities that received placebo (9.6 in Malawi, 27.5 in Niger, and 5.5 in Tanzania). Mortality was 13.5% lower overall (95% confidence interval [CI], 6.7 to 19.8) in communities that received azithromycin than in communities that received placebo (P<0.001); the rate was 5.7% lower in Malawi (95% CI, -9.7 to 18.9), 18.1% lower in Niger (95% CI, 10.0 to 25.5), and 3.4% lower in Tanzania (95% CI, -21.2 to 23.0). Children in the age group of 1 to 5 months had the greatest effect from azithromycin (24.9% lower mortality than that with placebo; 95% CI, 10.6 to 37.0). Serious adverse events occurring within a week after administration of the trial drug or placebo were uncommon, and the rate did not differ significantly between the groups. Evaluation of selection for antibiotic resistance is ongoing. CONCLUSIONS: Among postneonatal, preschool children in sub-Saharan Africa, childhood mortality was lower in communities randomly assigned to mass distribution of azithromycin than in those assigned to placebo, with the largest effect seen in Niger. Any implementation of a policy of mass distribution would need to strongly consider the potential effect of such a strategy on antibiotic resistance. (Funded by the Bill and Melinda Gates Foundation; MORDOR ClinicalTrials.gov number, NCT02047981 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Azithromycin and the Risk of Cardiovascular Death
Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G., & Stein, C. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1003833 · Cited by 954
Why do we need some large, simple randomized trials?
Yusuf, S., Collins, R., & Peto, R. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030421 · Cited by 699
Taylor, H. R., Burton, M. J., Haddad, D., West, S., & Wright, H. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62182-0 · Cited by 313
Self-citationAzithromycin in control of trachoma
Schachter, J., West, S. K., Mabey, D., Dawson, C. R., Bobo, L., Bailey, R., Vitale, S., Quinn, T. C., Sheta, A., Sallam, S., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12387-5 · Cited by 296
Self-citationUse of Azithromycin and Death from Cardiovascular Causes
Svanström, H., Pasternak, B., & Hviid, A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300799 · Cited by 254
Leach, A. J., Shelby-James, T. M., Mayo, M., Gratten, M., Laming, A. C., Currie, B. J., & Mathews, J. D. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.356 · Cited by 244
Porco, T. C., Gebre, T., Ayele, B., House, J., Keenan, J., Zhou, Z., Hong, K. C., Stoller, N., Ray, K. J., Emerson, P., et al. (2009) · JAMA · doi:10.1001/jama.2009.1266 · Cited by 202
Self-citationSkalet, A. H., Cevallos, V., Ayele, B., Gebre, T., Zhou, Z., Jorgensen, J. H., Zerihun, M., Habte, D., Assefa, Y., Emerson, P. M., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000377 · Cited by 140
Self-citationEffect of a Single Mass Antibiotic Distribution on the Prevalence of Infectious Trachoma
Chidambaram, J. D., Alemayehu, W., Melese, M., et al. (2006) · JAMA · doi:10.1001/jama.295.10.1142 · Cited by 136
Fry, A. M., Jha, H. C., Lietman, T. M., Chaudhary, J. S. P., Bhatta, R. C., Elliott, J. A., Hyde, T. B., Schuchat, A., Gaynor, B. J., & Dowell, S. F. (2002) · Clinical Infectious Diseases · doi:10.1086/341414 · Cited by 125
Self-citation
Cited by
Perin, J., Mulick, A., Yeung, D., Villavicencio, F., Lopez, G., Strong, K. L., Prieto-Merino, D., Cousens, S., Black, R. E., & Liu, L. (2022) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00311-4 · Cited by 1,667
Defining and combating antibiotic resistance from One Health and Global Health perspectives
Hernando-Amado, S., Coque, T. M., Baquero, F., & Martínez, J. L. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0503-9 · Cited by 1,224
Antibiotic Resistance: One Health One World Outlook
Aslam, B., Khurshid, M., Arshad, M. I., Muzammil, S., Rasool, M., Yasmeen, N., Shah, T., Chaudhry, T. H., Rasool, M. H., Shahid, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.771510 · Cited by 609
The challenge of antimicrobial resistance: What economics can contribute
Roope, L. S. J., Smith, R. D., Pouwels, K. B., Buchanan, J., Abel, L., Eibich, P., Butler, C. C., Tan, P. S., Walker, A. S., Robotham, J. V., et al. (2019) · Science · doi:10.1126/science.aau4679 · Cited by 575
Vulnerability of the industrialized microbiota
Sonnenburg, J. L., & Sonnenburg, E. D. (2019) · Science · doi:10.1126/science.aaw9255 · Cited by 326
Metadata
- Authors
- Keenan, J. D., Bailey, R. L., West, S. K., Arzika, A. M., Hart, J., Weaver, J., Kalua, K., Mrango, Z., Ray, K. J., Cook, C., Lebas, E., O’Brien, K. S., Emerson, P. M., Porco, T. C., & Lietman, T. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-04-26
- Volume
- 378
- Issue
- 17
- Pages
- 1583-1592
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2801239041
- Cited by
- 360
- References
- 20
- FWCI
- 44.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa. https://app.cochat.ai/papers/10.1056/nejmoa1715474
- The paper
- Keenan, J. D., Bailey, R. L., West, S. K., Arzika, A. M., Hart, J., Weaver, J., Kalua, K., Mrango, Z., Ray, K. J., Cook, C., Lebas, E., O’Brien, K. S., Emerson, P. M., Porco, T. C., & Lietman, T. M. (2018). Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1715474
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.